Abnormal	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Abnormal	Abnormal	JJ	JJ	_	4	amod	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	2	NF-kappa	NF-kappa	NN	NN	_	4	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	3	B	B	NN	NN	_	4	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	activity	activity	NN	NN	_	15	nsubjpass	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	in	in	IN	IN	_	7	case	_	_
T	NN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	6	T	T	NN	NN	_	7	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	7	lymphocytes	lymphocytes	NNS	NNS	_	4	nmod	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	from	from	IN	IN	_	9	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	9	patients	patients	NNS	NNS	_	7	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	with	with	IN	IN	_	13	case	_	_
systemic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	11	systemic	systemic	JJ	JJ	_	13	amod	_	_
lupus	NN	I-NP	O	Other	Other	Other	Other	Other	###	12	lupus	lupus	NN	NN	_	13	compound	_	_
erythematosus	NN	I-NP	O	Other	Other	Other	Other	Other	###	13	erythematosus	erythematosus	NN	NN	_	9	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	14	is	is	VBZ	VBZ	_	15	auxpass	_	_
associated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	15	associated	associated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	with	with	IN	IN	_	22	case	_	_
decreased	VBN	B-NP	O	Other	Other	Other	Other	Other	###	17	decreased	decreased	VBN	VBN	_	22	amod	_	_
p65	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	18	p65	p65	NN	NN	_	22	compound	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	19	-	-	-	-	_	22	punct	_	_
RelA	NN	B-NP	O	B-Protein	Other	Other	Other	Other	###	20	RelA	RelA	NN	NN	_	22	compound	_	_
protein	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	protein	protein	NN	NN	_	22	compound	_	_
expression	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	expression	expression	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	23	.	.	.	.	_	15	punct	_	_

Numerous	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Numerous	Numerous	JJ	JJ	_	5	amod	_	_
cellular	JJ	I-NP	O	Other	Other	Other	Other	Other	###	2	cellular	cellular	JJ	JJ	_	5	amod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	3	and	and	CC	CC	_	2	cc	_	_
biochemical	JJ	I-NP	O	Other	Other	Other	Other	Other	###	4	biochemical	biochemical	JJ	JJ	_	2	conj	_	_
abnormalities	NNS	I-NP	O	Other	Other	Other	Other	Other	###	5	abnormalities	abnormalities	NNS	NNS	_	11	nsubjpass	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	in	in	IN	IN	_	8	case	_	_
immune	JJ	B-NP	O	Other	Other	Other	Other	Other	###	7	immune	immune	JJ	JJ	_	8	amod	_	_
regulation	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	regulation	regulation	NN	NN	_	5	nmod	_	_
have	VBP	B-VP	O	Other	Other	Other	Other	Other	###	9	have	have	VBP	VBP	_	11	aux	_	_
been	VBN	I-VP	O	Other	Other	Other	Other	Other	###	10	been	been	VBN	VBN	_	11	auxpass	_	_
described	VBN	I-VP	O	Other	Other	Other	Other	Other	###	11	described	described	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	in	in	IN	IN	_	13	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	13	patients	patients	NNS	NNS	_	11	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	14	with	with	IN	IN	_	17	case	_	_
systemic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	15	systemic	systemic	JJ	JJ	_	17	amod	_	_
lupus	NN	I-NP	O	Other	Other	Other	Other	Other	###	16	lupus	lupus	NN	NN	_	17	compound	_	_
erythematosus	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	erythematosus	erythematosus	NN	NN	_	13	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	18	(	(	(	(	_	19	punct	_	_
SLE	NN	B-NP	O	Other	Other	Other	Other	Other	###	19	SLE	SLE	NN	NN	_	17	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	20	)	)	)	)	_	19	punct	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	21	,	,	,	,	_	13	punct	_	_
including	VBG	B-PP	O	Other	Other	Other	Other	Other	###	22	including	including	VBG	VBG	_	29	case	_	_
surface	NN	B-NP	O	Other	Other	Other	Other	Other	###	23	surface	surface	NN	NN	_	25	compound	_	_
Ag	NN	I-NP	O	Other	Other	Other	Other	Other	###	24	Ag	Ag	NN	NN	_	25	compound	_	_
receptor	JJ	I-NP	O	Other	Other	Other	Other	Other	###	25	receptor	receptor	JJ	JJ	_	29	compound	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	26	-	-	-	-	_	25	punct	_	_
initiated	JJ	I-NP	O	Other	Other	Other	Other	Other	###	27	initiated	initiated	JJ	JJ	_	29	amod	_	_
signaling	NN	I-NP	O	Other	Other	Other	Other	Other	###	28	signaling	signaling	NN	NN	_	29	compound	_	_
events	NNS	I-NP	O	Other	Other	Other	Other	Other	###	29	events	events	NNS	NNS	_	13	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	30	and	and	CC	CC	_	29	cc	_	_
lymphokine	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	31	lymphokine	lymphokine	NN	NN	_	32	compound	_	_
production	NN	I-NP	O	Other	Other	Other	Other	Other	###	32	production	production	NN	NN	_	29	conj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	33	.	.	.	.	_	11	punct	_	_

Because	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	1	Because	Because	IN	IN	_	4	mark	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	2	NF-kappa	NF-kappa	NN	NN	_	3	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	3	B	B	NN	NN	_	4	nsubj	_	_
contributes	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	4	contributes	contributes	VBZ	VBZ	_	26	advcl	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	5	to	to	TO	TO	_	7	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
transcription	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	transcription	transcription	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	of	of	IN	IN	_	11	case	_	_
numerous	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	numerous	numerous	JJ	JJ	_	11	amod	_	_
inflammatory	JJ	I-NP	B-DNA	Other	Other	Other	Other	Other	###	10	inflammatory	inflammatory	JJ	JJ	_	11	amod	_	_
genes	NNS	I-NP	I-DNA	Other	Other	Other	Other	Other	###	11	genes	genes	NNS	NNS	_	7	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	12	and	and	CC	CC	_	4	cc	_	_
has	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	13	has	has	VBZ	VBZ	_	15	aux	_	_
been	VBN	I-VP	O	Other	Other	Other	Other	Other	###	14	been	been	VBN	VBN	_	15	auxpass	_	_
shown	VBN	I-VP	O	Other	Other	Other	Other	Other	###	15	shown	shown	VBN	VBN	_	4	conj	_	_
to	TO	I-VP	O	Other	Other	Other	Other	Other	###	16	to	to	TO	TO	_	20	mark	_	_
be	VB	I-VP	O	Other	Other	Other	Other	Other	###	17	be	be	VB	VB	_	20	cop	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	18	a	a	DT	DT	_	20	det	_	_
molecular	JJ	I-NP	O	Other	Other	Other	Other	Other	###	19	molecular	molecular	JJ	JJ	_	20	amod	_	_
target	NN	I-NP	O	Other	Other	Other	Other	Other	###	20	target	target	NN	NN	_	15	xcomp	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	21	of	of	IN	IN	_	23	case	_	_
antiinflammatory	JJ	B-NP	O	Other	Other	Other	Other	Other	###	22	antiinflammatory	antiinflammatory	JJ	JJ	_	23	amod	_	_
drugs	NNS	I-NP	O	Other	Other	Other	Other	Other	###	23	drugs	drugs	NNS	NNS	_	20	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	24	,	,	,	,	_	26	punct	_	_
we	PRP	B-NP	O	Other	Other	Other	Other	Other	###	25	we	we	PRP	PRP	_	26	nsubj	_	_
sought	VBD	B-VP	O	Other	Other	Other	Other	Other	###	26	sought	sought	VBD	VBD	_	0	root	_	_
to	TO	I-VP	O	Other	Other	Other	Other	Other	###	27	to	to	TO	TO	_	28	mark	_	_
characterize	VB	I-VP	O	Other	Other	Other	Other	Other	###	28	characterize	characterize	VB	VB	_	26	xcomp	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	29	the	the	DT	DT	_	31	det	_	_
functional	JJ	I-NP	O	Other	Other	Other	Other	Other	###	30	functional	functional	JJ	JJ	_	31	amod	_	_
role	NN	I-NP	O	Other	Other	Other	Other	Other	###	31	role	role	NN	NN	_	28	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	32	of	of	IN	IN	_	37	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	33	the	the	DT	DT	_	37	det	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	34	NF-kappa	NF-kappa	NN	NN	_	37	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	35	B	B	NN	NN	_	37	compound	_	_
protein	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	36	protein	protein	NN	NN	_	37	compound	_	_
complex	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	37	complex	complex	NN	NN	_	31	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	38	in	in	IN	IN	_	41	case	_	_
lupus	NN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	39	lupus	lupus	NN	NN	_	41	compound	_	_
T	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	40	T	T	NN	NN	_	41	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	41	cells	cells	NNS	NNS	_	31	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	42	.	.	.	.	_	26	punct	_	_

Freshly	RB	B-NP	O	Other	Other	Other	Other	Other	###	1	Freshly	Freshly	RB	RB	_	4	advmod	_	_
isolated	VBN	I-NP	O	Other	Other	Other	Other	Other	###	2	isolated	isolated	VBN	VBN	_	4	amod	_	_
T	NN	I-NP	B-cell_type	Other	Other	Other	Other	Other	###	3	T	T	NN	NN	_	4	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	4	cells	cells	NNS	NNS	_	20	nsubjpass	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	from	from	IN	IN	_	7	case	_	_
lupus	NN	B-NP	O	Other	Other	Other	Other	Other	###	6	lupus	lupus	NN	NN	_	7	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	7	patients	patients	NNS	NNS	_	4	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	8	,	,	,	,	_	7	punct	_	_
rheumatoid	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	rheumatoid	rheumatoid	JJ	JJ	_	10	amod	_	_
arthritis	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	arthritis	arthritis	NN	NN	_	14	compound	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	11	(	(	(	(	_	12	punct	_	_
RA	NN	B-NP	O	Other	Other	Other	Other	Other	###	12	RA	RA	NN	NN	_	10	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	13	)	)	)	)	_	12	punct	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	14	patients	patients	NNS	NNS	_	7	conj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	15	,	,	,	,	_	7	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	16	and	and	CC	CC	_	7	cc	_	_
normal	JJ	B-NP	O	Other	Other	Other	Other	Other	###	17	normal	normal	JJ	JJ	_	18	amod	_	_
individuals	NNS	I-NP	O	Other	Other	Other	Other	Other	###	18	individuals	individuals	NNS	NNS	_	7	conj	_	_
were	VBD	B-VP	O	Other	Other	Other	Other	Other	###	19	were	were	VBD	VBD	_	20	auxpass	_	_
activated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	20	activated	activated	VBN	VBN	_	0	root	_	_
physiologically	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	21	physiologically	physiologically	RB	RB	_	20	advmod	_	_
via	IN	B-PP	O	Other	Other	Other	Other	Other	###	22	via	via	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	23	the	the	DT	DT	_	24	det	_	_
TCR	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	24	TCR	TCR	NN	NN	_	20	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	with	with	IN	IN	_	26	case	_	_
anti-CD3	JJ	B-NP	B-protein	Other	Other	Other	Other	Other	###	26	anti-CD3	anti-CD3	JJ	JJ	_	20	nmod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	27	and	and	CC	CC	_	26	cc	_	_
anti	NN	B-NP	O	Other	Other	Other	Other	Other	###	28	anti	anti	NN	NN	_	26	conj	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	29	-	-	-	-	_	26	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	30	CD28	CD28	NN	NN	_	31	compound	_	_
Abs	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	31	Abs	Abs	NNS	NNS	_	26	dep	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	32	to	to	TO	TO	_	33	mark	_	_
assess	VB	I-VP	O	Other	Other	Other	Other	Other	###	33	assess	assess	VB	VB	_	20	xcomp	_	_
proximal	JJ	B-NP	O	Other	Other	Other	Other	Other	###	34	proximal	proximal	JJ	JJ	_	36	amod	_	_
membrane	NN	I-NP	O	Other	Other	Other	Other	Other	###	35	membrane	membrane	NN	NN	_	36	compound	_	_
signaling	NN	I-NP	O	Other	Other	Other	Other	Other	###	36	signaling	signaling	NN	NN	_	33	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	37	,	,	,	,	_	33	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	38	and	and	CC	CC	_	33	cc	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	39	with	with	IN	IN	_	40	case	_	_
PMA	NN	B-NP	O	Other	Other	Other	Other	Other	###	40	PMA	PMA	NN	NN	_	49	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	41	and	and	CC	CC	_	40	cc	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	42	a	a	DT	DT	_	44	det	_	_
calcium	NN	I-NP	O	Other	Other	Other	Other	Other	###	43	calcium	calcium	NN	NN	_	44	compound	_	_
ionophore	NN	I-NP	O	Other	Other	Other	Other	Other	###	44	ionophore	ionophore	NN	NN	_	40	conj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	45	(	(	(	(	_	46	punct	_	_
A23187	NN	B-NP	O	Other	Other	Other	Other	Other	###	46	A23187	A23187	NN	NN	_	44	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	47	)	)	)	)	_	46	punct	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	48	to	to	TO	TO	_	49	mark	_	_
bypass	VB	I-VP	O	Other	Other	Other	Other	Other	###	49	bypass	bypass	VB	VB	_	33	conj	_	_
membrane	JJ	B-NP	O	Other	Other	Other	Other	Other	###	50	membrane	membrane	JJ	JJ	_	54	amod	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	51	-	-	-	-	_	52	punct	_	_
mediated	JJ	B-NP	O	Other	Other	Other	Other	Other	###	52	mediated	mediated	JJ	JJ	_	54	amod	_	_
signaling	NN	I-NP	O	Other	Other	Other	Other	Other	###	53	signaling	signaling	NN	NN	_	54	compound	_	_
events	NNS	I-NP	O	Other	Other	Other	Other	Other	###	54	events	events	NNS	NNS	_	49	dobj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	55	.	.	.	.	_	20	punct	_	_

We	PRP	B-NP	O	Other	Other	Other	Other	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
measured	VBD	B-VP	O	Other	Other	Other	Other	Other	###	2	measured	measured	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	3	the	the	DT	DT	_	7	det	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	4	NF-kappa	NF-kappa	NN	NN	_	7	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	5	B	B	NN	NN	_	7	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	binding	binding	NN	NN	_	7	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	activity	activity	NN	NN	_	2	dobj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	in	in	IN	IN	_	10	case	_	_
nuclear	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
extracts	NNS	I-NP	O	Other	Other	Other	Other	Other	###	10	extracts	extracts	NNS	NNS	_	7	nmod	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	11	by	by	IN	IN	_	14	case	_	_
gel	NN	B-NP	O	Other	Other	Other	Other	Other	###	12	gel	gel	NN	NN	_	14	compound	_	_
shift	NN	I-NP	O	Other	Other	Other	Other	Other	###	13	shift	shift	NN	NN	_	14	compound	_	_
analysis	NN	I-NP	O	Other	Other	Other	Other	Other	###	14	analysis	analysis	NN	NN	_	2	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	15	.	.	.	.	_	2	punct	_	_

When	WRB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	When	When	WRB	WRB	_	2	advmod	_	_
compared	VBN	B-PP	O	Other	Other	Other	Other	Other	###	2	compared	compared	VBN	VBN	_	18	advcl	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	3	with	with	IN	IN	_	5	case	_	_
normal	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	4	normal	normal	JJ	JJ	_	5	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	5	cells	cells	NNS	NNS	_	2	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	6	,	,	,	,	_	18	punct	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	activation	activation	NN	NN	_	18	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	12	case	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	10	NF-kappa	NF-kappa	NN	NN	_	12	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	11	B	B	NN	NN	_	12	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	12	activity	activity	NN	NN	_	8	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	13	in	in	IN	IN	_	15	case	_	_
SLE	NN	B-NP	O	Other	Other	Other	Other	Other	###	14	SLE	SLE	NN	NN	_	15	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	15	patients	patients	NNS	NNS	_	8	nmod	_	_
was	VBD	B-VP	O	Other	Other	Other	Other	Other	###	16	was	was	VBD	VBD	_	18	auxpass	_	_
significantly	RB	I-VP	O	Other	Other	Other	Other	Other	###	17	significantly	significantly	RB	RB	_	18	advmod	_	_
decreased	VBN	I-VP	O	Other	Other	Other	Other	Other	###	18	decreased	decreased	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	19	in	in	IN	IN	_	27	case	_	_
SLE	NN	B-NP	O	Other	Other	Other	Other	Other	###	20	SLE	SLE	NN	NN	_	27	nmod	_	_
,	,	B-PP	O	Other	Other	Other	Other	Other	###	21	,	,	,	,	_	27	punct	_	_
but	CC	I-PP	O	Other	Other	Other	Other	Other	###	22	but	but	CC	CC	_	27	cc	_	_
not	RB	B-PP	O	Other	Other	Other	Other	Other	###	23	not	not	RB	RB	_	25	neg	_	_
in	IN	I-PP	O	Other	Other	Other	Other	Other	###	24	in	in	IN	IN	_	25	case	_	_
RA	NN	B-NP	O	Other	Other	Other	Other	Other	###	25	RA	RA	NN	NN	_	27	conj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	26	,	,	,	,	_	27	punct	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	27	patients	patients	NNS	NNS	_	18	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	28	.	.	.	.	_	18	punct	_	_

NF-kappa	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	1	NF-kappa	NF-kappa	NN	NN	_	4	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	2	B	B	NN	NN	_	4	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	binding	binding	NN	NN	_	4	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	activity	activity	NN	NN	_	6	nsubj	_	_
was	VBD	B-VP	O	Other	Other	Other	Other	Other	###	5	was	was	VBD	VBD	_	6	cop	_	_
absent	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	6	absent	absent	JJ	JJ	_	0	root	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	in	in	IN	IN	_	10	case	_	_
several	JJ	B-NP	O	Other	Other	Other	Other	Other	###	8	several	several	JJ	JJ	_	10	amod	_	_
SLE	NN	I-NP	O	Other	Other	Other	Other	Other	###	9	SLE	SLE	NN	NN	_	10	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	10	patients	patients	NNS	NNS	_	6	nmod	_	_
who	WP	B-NP	O	Other	Other	Other	Other	Other	###	11	who	who	WP	WP	_	14	nsubj	_	_
were	VBD	B-VP	O	Other	Other	Other	Other	Other	###	12	were	were	VBD	VBD	_	14	aux	_	_
not	RB	I-VP	O	Other	Other	Other	Other	Other	###	13	not	not	RB	RB	_	14	neg	_	_
receiving	VBG	I-VP	O	Other	Other	Other	Other	Other	###	14	receiving	receiving	VBG	VBG	_	10	acl:relcl	_	_
any	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	any	any	DT	DT	_	16	det	_	_
medication	NN	I-NP	O	Other	Other	Other	Other	Other	###	16	medication	medication	NN	NN	_	14	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	17	,	,	,	,	_	16	punct	_	_
including	VBG	B-PP	O	Other	Other	Other	Other	Other	###	18	including	including	VBG	VBG	_	19	case	_	_
corticosteroids	NNS	B-NP	O	Other	Other	Other	Other	Other	###	19	corticosteroids	corticosteroids	NNS	NNS	_	16	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	20	.	.	.	.	_	6	punct	_	_

Also	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Also	Also	RB	RB	_	6	advmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	2	,	,	,	,	_	6	punct	_	_
NF-kappa	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	3	NF-kappa	NF-kappa	NN	NN	_	5	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	4	B	B	NN	NN	_	5	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	activity	activity	NN	NN	_	6	nsubj	_	_
remained	VBD	B-VP	O	Other	Other	Other	Other	Other	###	6	remained	remained	VBD	VBD	_	0	root	_	_
absent	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	7	absent	absent	JJ	JJ	_	6	xcomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	in	in	IN	IN	_	10	case	_	_
follow-up	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	follow-up	follow-up	JJ	JJ	_	10	amod	_	_
studies	NNS	I-NP	O	Other	Other	Other	Other	Other	###	10	studies	studies	NNS	NNS	_	7	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	11	.	.	.	.	_	6	punct	_	_

In	IN	B-PP	O	Other	Other	Other	Other	Other	###	1	In	In	IN	IN	_	3	case	_	_
supershift	NN	B-NP	O	Other	Other	Other	Other	Other	###	2	supershift	supershift	NN	NN	_	3	compound	_	_
experiments	NNS	I-NP	O	Other	Other	Other	Other	Other	###	3	experiments	experiments	NNS	NNS	_	9	nmod	_	_
using	VBG	B-VP	O	Other	Other	Other	Other	Other	###	4	using	using	VBG	VBG	_	3	acl	_	_
specific	JJ	B-NP	B-protein	Other	Other	Other	Other	Other	###	5	specific	specific	JJ	JJ	_	6	amod	_	_
Abs	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	6	Abs	Abs	NNS	NNS	_	4	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	7	,	,	,	,	_	9	punct	_	_
we	PRP	B-NP	O	Other	Other	Other	Other	Other	###	8	we	we	PRP	PRP	_	9	nsubj	_	_
showed	VBD	B-VP	O	Other	Other	Other	Other	Other	###	9	showed	showed	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	10	that	that	IN	IN	_	29	mark	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	11	,	,	,	,	_	29	punct	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	in	in	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	13	the	the	DT	DT	_	14	det	_	_
group	NN	I-NP	O	Other	Other	Other	Other	Other	###	14	group	group	NN	NN	_	29	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	15	of	of	IN	IN	_	17	case	_	_
SLE	NN	B-NP	O	Other	Other	Other	Other	Other	###	16	SLE	SLE	NN	NN	_	17	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	17	patients	patients	NNS	NNS	_	14	nmod	_	_
who	WP	B-NP	O	Other	Other	Other	Other	Other	###	18	who	who	WP	WP	_	19	nsubj	_	_
displayed	VBD	B-VP	O	Other	Other	Other	Other	Other	###	19	displayed	displayed	VBD	VBD	_	17	acl:relcl	_	_
undetectable	JJ	B-NP	O	Other	Other	Other	Other	Other	###	20	undetectable	undetectable	JJ	JJ	_	23	amod	_	_
NF-kappa	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	21	NF-kappa	NF-kappa	NN	NN	_	23	compound	_	_
B	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	22	B	B	NN	NN	_	23	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	23	activity	activity	NN	NN	_	19	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	24	,	,	,	,	_	29	punct	_	_
p65	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	25	p65	p65	NN	NN	_	26	compound	_	_
complexes	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	26	complexes	complexes	NNS	NNS	_	29	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	Other	Other	Other	###	27	were	were	VBD	VBD	_	29	auxpass	_	_
not	RB	I-VP	O	Other	Other	Other	Other	Other	###	28	not	not	RB	RB	_	29	neg	_	_
formed	VBN	I-VP	O	Other	Other	Other	Other	Other	###	29	formed	formed	VBN	VBN	_	9	ccomp	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	30	.	.	.	.	_	9	punct	_	_

Finally	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Finally	Finally	RB	RB	_	8	advmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	2	,	,	,	,	_	8	punct	_	_
immunoblot	NN	B-NP	O	Other	Other	Other	Other	Other	###	3	immunoblot	immunoblot	NN	NN	_	4	compound	_	_
analysis	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	analysis	analysis	NN	NN	_	8	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	of	of	IN	IN	_	7	case	_	_
nuclear	JJ	B-NP	O	Other	Other	Other	Other	Other	###	6	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
extracts	NNS	I-NP	O	Other	Other	Other	Other	Other	###	7	extracts	extracts	NNS	NNS	_	4	nmod	_	_
showed	VBD	B-VP	O	Other	Other	Other	Other	Other	###	8	showed	showed	VBD	VBD	_	0	root	_	_
decreased	VBN	B-VP	O	Other	Other	Other	Other	B-Negative_regulation	###	9	decreased	decreased	VBN	VBN	_	14	amod	_	_
or	CC	O	O	Other	Other	Other	Other	I-Negative_regulation	###	10	or	or	CC	CC	_	9	cc	_	_
absent	JJ	B-NP	O	Other	Other	Other	Other	I-Negative_regulation	###	11	absent	absent	JJ	JJ	_	9	conj	_	_
p65	NN	I-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	12	p65	p65	NN	NN	_	14	compound	_	_
protein	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	13	protein	protein	NN	NN	_	14	compound	_	_
levels	NNS	I-NP	O	Other	Other	Other	Other	Other	###	14	levels	levels	NNS	NNS	_	8	dobj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	15	.	.	.	.	_	8	punct	_	_

As	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	1	As	As	IN	IN	_	6	mark	_	_
p65	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	2	p65	p65	NN	NN	_	3	compound	_	_
complexes	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	3	complexes	complexes	NNS	NNS	_	6	nsubj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	4	are	are	VBP	VBP	_	6	cop	_	_
transcriptionally	RB	B-ADJP	O	Other	Other	Other	Other	B-Positive_regulation	###	5	transcriptionally	transcriptionally	RB	RB	_	6	advmod	_	_
active	JJ	I-ADJP	O	Other	Other	Other	Other	I-Positive_regulation	###	6	active	active	JJ	JJ	_	18	advcl	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	in	in	IN	IN	_	8	case	_	_
comparison	NN	B-NP	O	Other	Other	Other	Other	Other	###	8	comparison	comparison	NN	NN	_	6	nmod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	9	to	to	TO	TO	_	12	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	10	the	the	DT	DT	_	12	det	_	_
p50	NN	I-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	11	p50	p50	NN	NN	_	12	compound	_	_
homodimer	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	12	homodimer	homodimer	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	13	,	,	,	,	_	18	punct	_	_
this	DT	B-NP	O	Other	Other	Other	Other	Other	###	14	this	this	DT	DT	_	16	det	_	_
novel	JJ	I-NP	O	Other	Other	Other	Other	Other	###	15	novel	novel	JJ	JJ	_	16	amod	_	_
finding	NN	I-NP	O	Other	Other	Other	Other	Other	###	16	finding	finding	NN	NN	_	18	nsubj	_	_
may	MD	B-VP	O	Other	Other	Other	Other	Other	###	17	may	may	MD	MD	_	18	aux	_	_
provide	VB	I-VP	O	Other	Other	Other	Other	Other	###	18	provide	provide	VB	VB	_	0	root	_	_
insight	NN	B-NP	O	Other	Other	Other	Other	Other	###	19	insight	insight	NN	NN	_	18	dobj	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	on	on	IN	IN	_	22	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	21	the	the	DT	DT	_	22	det	_	_
origin	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	origin	origin	NN	NN	_	19	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	23	of	of	IN	IN	_	25	case	_	_
abnormal	JJ	B-NP	B-protein	Other	Other	Other	Other	Other	###	24	abnormal	abnormal	JJ	JJ	_	25	amod	_	_
cytokine	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	25	cytokine	cytokine	NN	NN	_	22	nmod	_	_
or	CC	O	O	Other	Other	Other	Other	Other	###	26	or	or	CC	CC	_	25	cc	_	_
other	JJ	B-NP	O	Other	Other	Other	Other	Other	###	27	other	other	JJ	JJ	_	29	amod	_	_
gene	NN	I-NP	O	Other	Other	Other	Other	Other	###	28	gene	gene	NN	NN	_	29	compound	_	_
transcription	NN	I-NP	O	Other	Other	Other	Other	Other	###	29	transcription	transcription	NN	NN	_	25	conj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	30	in	in	IN	IN	_	32	case	_	_
SLE	NN	B-NP	O	Other	Other	Other	Other	Other	###	31	SLE	SLE	NN	NN	_	32	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	32	patients	patients	NNS	NNS	_	25	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	33	.	.	.	.	_	18	punct	_	_

